Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Zepp Health Corp (ZEPP)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Zepp Health's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.8849 +0.0449    +5.35%
26/04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.8530
-0.0319
-3.6049%
19:00:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 50,571
  • Bid/Ask: 0.8400 / 0.9500
  • Day's Range: 0.8400 - 0.9000
Zepp Health 0.8849 +0.0449 +5.35%

ZEPP Ratios

 
Assess the performance of Zepp Health (ZEPP). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Zepp Health Corp's latest financial reports. Compare the performance metrics of Zepp Health (ZEPP) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM -1.81 26.69
Price to Sales TTM 0.15 5.7
Price to Cash Flow MRQ 1.29 18.5
Price to Free Cash Flow TTM 1.34 12.8
Price to Book MRQ 0.15 25.01
Price to Tangible Book MRQ 0.16 23.63
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 26.36% 39.86
Gross Margin 5YA 22.18% 37.61
Operating margin TTM -8.3% 22.07
Operating margin 5YA 0.77% 21.22
Pretax margin TTM -9.15% 20.68
Pretax margin 5YA 1.52% 19.46
Net Profit margin TTM -8.5% 17.35
Net Profit margin 5YA 1.47% 16.13
   
Revenue/Share TTM 40.88 4,482.12
Basic EPS ANN -3.49 261.49
Diluted EPS ANN -3.49 261.27
Book Value/Share MRQ 40.84 5,586.19
Tangible Book Value/Share MRQ 39.11 5,074.54
Cash/Share MRQ 15.55 1,075.78
Cash Flow/Share TTM 4.89 722.37
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM -8.21% 112.15
Return on Equity 5YA 6.46% 90.58
Return on Assets TTM -4.35% 21.72
Return on Assets 5YA 3.68% 18.42
Return on Investment TTM -5% 42.66
Return on Investment 5YA 5.13% 32.14
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 88.69% 14.41
EPS(TTM) vs TTM 1 Yr. Ago TTM 25.47% -2.15
5 Year EPS Growth 5YA 0% 11
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ -44.04% 3.47
Sales (TTM) vs TTM 1 Yr. Ago TTM -39.77% -0.78
5 Year Sales Growth 5YA -7.3% 6.5
5 Year Capital Spending Growth 5YA 0% 0.42
   
Quick Ratio MRQ 1.34 0.81
Current Ratio MRQ 2.04 1.25
LT Debt to Equity MRQ 34.19% 96.06
Total Debt to Equity MRQ 35.58% 79.07
Efficiency    
Asset Turnover TTM 0.51 1.01
Inventory Turnover TTM 2.26 24.45
Revenue/Employee TTM - 8.69M
Net Income/Employee TTM - 890.68K
Receivable Turnover TTM 4.59 15.55
   
Dividend Yield ANN - 0.59
Dividend Yield 5 Year Avg. 5YA - 1.08
Dividend Growth Rate ANN 0% 4.31
Payout Ratio TTM - 19.51
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ZEPP Comments

Write your thoughts about Zepp Health Corp
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
egbert welse
egbert welse Apr 29, 2022 9:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy for 5.5
Reply
2 0
Report
Casmir Gindol
Casmir Gindol Jan 11, 2022 10:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I like amazefit
Reply
2 0
Report
Argenis Quintero
Argenis1979 Dec 20, 2021 11:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Time to buy Zepp.
Reply
4 1
Report
Szilvia Vamos
Szilvia Vamos Jul 13, 2021 8:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Full of good news today guys: https://finance.yahoo.com/news/zepp-health-introduces-next-gen-114100550.html
Reply
1 0
Report
Zoltán Kiss
Zoltán Kiss Jul 13, 2021 8:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jó, hogy olcsón bevásároltam ebből kb. 1,5 hónapja :)
Reply
2 0
Report
Szilvia Vamos
Szilvia Vamos Jul 13, 2021 8:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
igen, szerintem is jól tetted ;)
Reply
1 0
Report
Balazs Koleszar
RiderBaloo Jul 13, 2021 8:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://huami.cdn.bcebos.com/uploads/ir-files/611e3a958497c.pdf
Reply
1 0
Report
Szilvia Vamos
Szilvia Vamos Jul 13, 2021 7:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Finally, things start to make sense, PAI Healh is owned by Zepp health: https://www.globenewswire.com/news-release/2021/07/13/2261766/0/en/PAI-Health-partners-with-Zurich-Brazil-with-the-goal-of-improving-health-outcomes.html
Reply
1 0
Report
Szilvia Vamos
Szilvia Vamos Jul 10, 2021 4:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://finance.yahoo.com/news/amazfits-upcoming-product-redefine-tws-130000006.html
Reply
1 0
Report
Szilvia Vamos
Szilvia Vamos May 14, 2021 11:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
short sqeeze here too?
Reply
1 0
Report
Gerald Broflowski
Gerald Broflowski May 13, 2021 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
looks bad
Reply
2 2
Report
Szilvia Vamos
Szilvia Vamos May 13, 2021 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes, quite ugly, I beleive in them and their projections so I will hold more...
Reply
0 0
Report
Gerald Broflowski
Gerald Broflowski May 13, 2021 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I will buy back some shares once I see it clearly.
Reply
1 0
Report
Szilvia Vamos
Szilvia Vamos May 13, 2021 11:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yeah, good idea! Let's see, I already did my bet, so I will see if I am going to be a bag holder or very nicely rewarded for my patience :D However I see good signs, they grow a lot the sales of Zepp brand and I cannot forget the 2 other business opportunities to build their ecosystem as a heathcare company and health insurance business. They "only" have to execute, fingers crossed, good luck for you and a lot of patience ;)
Reply
0 0
Report
Szilvia Vamos
Szilvia Vamos May 13, 2021 6:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Zepp Health Corp. (NYSE: ZEPP) today reported revenue of RMB1.1 billion (US$175.1 million); GAAP diluted net loss per share of RMB0.16 (US$0.02); and GAAP diluted net loss per ADS of RMB0.64 (US$0.10) for the first quarter ended March 31, 2021. Each ADS represents four (4) Class A ordinary shares.
Reply
2 0
Report
Show previous replies (1)
Daniele Ongari
Daniele Ongari May 13, 2021 6:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
at least they provide some positive guidance in the revenue of next quarter: "Net revenues to be between RMB1.7 billion and RMB1.8 billion, compared with RMB1.14 billion in the second quarter of 2020" Let's see if the army of new salesmen and researchers was worth
Reply
1 0
Report
Daniele Ongari
Daniele Ongari May 13, 2021 6:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
...but not so bad after all: the guidance for next quarter is good and the revenue from self-branded product is expanding. Let's see if this massive hiring of salesmen and researchers will translate in real growth
Reply
1 0
Report
Daniele Ongari
Daniele Ongari May 13, 2021 6:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
...but not so bad after all: the guidance for next quarter is good and the revenue from self-branded product is expanding. Let's see if this massive hiring of salesmen and researchers will translate in real growth
Reply
0 0
Report
Daniele Ongari
Daniele Ongari May 13, 2021 6:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
...but not so bad after all: the guidance for next quarter is good and the revenue from self-branded product is expanding. Let's see if this massive hiring of salesmen and researchers will translate in real growth
Reply
0 0
Report
Szilvia Vamos
Szilvia Vamos May 13, 2021 6:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Doesn't look good the net loss... a bit painful after all this downtrend and not so good news even from Q4 and now in Q1 however the guidence seems ambitious for Q2."second quarter of 2021, the management of the Company currently expects:-  Net revenues to be between RMB1.7 billion and RMB1.8 billion, compared with RMB1.14 billion in the second quarter of 2020.""Our strong guidance for the second quarter reflects our expectation of continued strength of our Amazfit and Zepp brands, as well as new Xiaomi shipments. While we continue to manage expenses, the ongoing pandemic has brought challenges to our expense coverage, and we keep investing in the growth of our business. We expect to return to GAAP profitability in Q2 this year."
Reply
1 0
Report
Szilvia Vamos
Szilvia Vamos May 05, 2021 10:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Maybe someone is here beside me: first quarter of 2021 unaudited financial results before the market open on Thursday, May 13, 2021.
Reply
2 0
Report
Gerald Broflowski
Gerald Broflowski May 05, 2021 10:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This thing looks like it's gone bankrupt. I don't know what to expect of the earnings.
Reply
1 0
Report
Szilvia Vamos
Szilvia Vamos May 05, 2021 10:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
to be honest me neither but it's extremely undervalued. Hopefully this year Zepp will have some good news, they start to execute on the other 2 pillars and move to the healthcare business beside changin the name :D being Xiaomi whatch manufacturer is nice but the future can be brighter but let's see how they execute. I am very curiois about the insurance business opportunity too, there can be many growth optionssss I just want to see some already :D
Reply
1 0
Report
Gerald Broflowski
Gerald Broflowski May 05, 2021 10:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
now we know this is not undervalued at all. It can drop another 50% and still wouldn't be undervalued
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email